Inari Medical (NARI) Competitors

Cantel Medical (NYSE:CMD) and Inari Medical (NASDAQ:NARI) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends.

Which has more risk and volatility, CMD or NARI?

Cantel Medical has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Comparatively, Inari Medical has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500.

Do analysts prefer CMD or NARI?

Inari Medical has a consensus price target of $58.89, suggesting a potential upside of 16.47%. Given Inari Medical's stronger consensus rating and higher probable upside, analysts plainly believe Inari Medical is more favorable than Cantel Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cantel Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Inari Medical	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.45

Which has better earnings & valuation, CMD or NARI?

Cantel Medical has higher revenue and earnings than Inari Medical. Inari Medical is trading at a lower price-to-earnings ratio than Cantel Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cantel Medical	$1.02B	3.52	$13.71M	$1.65	48.71
Inari Medical	$493.63M	6.00	-$1.64M	-$1.35	-37.45

Does the MarketBeat Community believe in CMD or NARI?

Cantel Medical received 146 more outperform votes than Inari Medical when rated by MarketBeat users. Likewise, 65.53% of users gave Cantel Medical an outperform vote while only 61.90% of users gave Inari Medical an outperform vote.

Company	Underperform	Outperform
Cantel Medical	Outperform Votes 211 65.53%	Underperform Votes 111 34.47%
Inari Medical	Outperform Votes 65 61.90%	Underperform Votes 40 38.10%

Is CMD or NARI more profitable?

Cantel Medical has a net margin of 4.72% compared to Inari Medical's net margin of -13.68%. Cantel Medical's return on equity of 12.13% beat Inari Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cantel Medical	4.72%	12.13%	4.45%
Inari Medical	-13.68%	-10.09%	-6.60%

Do institutionals & insiders have more ownership in CMD or NARI?

84.1% of Cantel Medical shares are held by institutional investors. Comparatively, 91.0% of Inari Medical shares are held by institutional investors. 10.7% of Cantel Medical shares are held by insiders. Comparatively, 10.6% of Inari Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the media favor CMD or NARI?

In the previous week, Inari Medical had 4 more articles in the media than Cantel Medical. MarketBeat recorded 4 mentions for Inari Medical and 0 mentions for Cantel Medical. Inari Medical's average media sentiment score of 1.19 beat Cantel Medical's score of 0.00 indicating that Inari Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Cantel Medical	Neutral
Inari Medical	Positive

Summary

Cantel Medical beats Inari Medical on 11 of the 18 factors compared between the two stocks.